Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan/Carboplatin +/- Cetuximab in Metastatic Breast Cancer
NCT00248287Phase 2Active, not recruiting
- Sponsor
- US Oncology Network
- Start
- Jul 2005
- Primary completion
- Dec 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in breast cancer, sponsored by US Oncology Network. Started Jul 2005; status: active, not recruiting.
02
Drugs
cetuximab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00248287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248287.